UMIN-CTR Clinical Trial

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000037968
Receipt No. R000043212
Scientific Title Comprehensive analysis of bronchoalveolar lavage fluid in diffuse lung diseases
Date of disclosure of the study information 2019/09/09
Last modified on 2021/09/11 (Ver. 10)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Comprehensive analysis of bronchoalveolar lavage fluid in diffuse lung diseases
Acronym Comprehensive analysis of bronchoalveolar lavage fluid in diffuse lung diseases
Scientific Title Comprehensive analysis of bronchoalveolar lavage fluid in diffuse lung diseases
Scientific Title:Acronym Comprehensive analysis of bronchoalveolar lavage fluid in diffuse lung diseases
Region
Japan

Condition
Condition Diffuse lung disease
Classification by specialty
Pneumology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate pathology of various diffuse lung diseases
Basic objectives2 Others
Basic objectives -Others To investigate pathology of various diffuse lung diseases
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Comprehensive analysis of various elements in bronchoalveolar lavage fluid
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Subjects who undertook bronchoscopy due to their diffuse lung disease
Key exclusion criteria Under 20 years old
Target sample size 90

Research contact person
Name of lead principal investigator
1st name Shonosuke
Middle name
Last name Tajima
Organization Kawasaki Medical School
Division name Respiratory Medicine
Zip code 701-0162
Address 577 matsushima, Kurashiki city
TEL 086-462-1111
Email shonosuke@med.kawasaki-m.ac.jp

Public contact
Name of contact person
1st name Shonosuke
Middle name
Last name Tajima
Organization Kawasai Medical School
Division name Respiratory Medicine
Zip code 700-0162
Address 577 matsushima, Kurashiki city
TEL 086-462-1111
Homepage URL
Email shonosuke@med.kawasaki-m.ac.jp

Sponsor
Institute Kawasaki Medical School
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Kawasaki Medical School ethics committee
Address 577 matsushima, Kurashiki city
Tel 086-464-1076
Email Kmsrec@med.kawasaki-m.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 09 Month 09 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 95
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2019 Year 10 Month 01 Day
Date of IRB
2019 Year 11 Month 11 Day
Anticipated trial start date
2019 Year 10 Month 01 Day
Last follow-up date
2021 Year 10 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information The subject is a person who performs bronchoscopy for diffuse lung disease over the age of 20 years. If consent is obtained, use bronchoalveolar lavage fluid and blood samples.The recrusent period is when 90 cases of the planned number of cases are gathered.

Management information
Registered date
2019 Year 09 Month 09 Day
Last modified on
2021 Year 09 Month 11 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043212